Fragment Library

Information

• G2019S LRRK2 Parkinson's Disease program

• ALK Neuroblastoma program

We are pioneers in the field of Fragment-based Lead Discovery

• Founders are inventors of crystallographic and NMR-based screening

• Team has contributed to four FBLD derived IND

We have adapted FBLD to address key challenges in CNS drug discovery

• Custom CNS directed fragment library

• Computational tools engineering CNS compatible physiochemical properties

We offer FBLD services

• Commercial fragment library collections

• Fragment-screening and lead discovery

• x-ray crystallography